Dopamine D-2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal

被引:179
作者
Wang, GJ
Volkow, ND
Fowler, JS
Logan, J
Abumrad, NN
Hitzemann, RJ
Pappas, NS
Pascani, K
机构
[1] BROOKHAVEN NATL LAB,DEPT CHEM,UPTON,NY 11973
[2] SUNY STONY BROOK,DEPT RADIOL,STONY BROOK,NY 11794
[3] SUNY STONY BROOK,DEPT PSYCHIAT,STONY BROOK,NY 11794
[4] VET AFFAIRS MED CTR,PSYCHIAT SERV,NORTHPORT,NY
[5] N SHORE UNIV HOSP,DEPT SURG,MANHASSET,NY
关键词
naloxone; opiate abuse; PET; withdrawal;
D O I
10.1016/S0893-133X(96)00184-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine may play a role in opiate withdrawal and dependence. We measured dopamine D-2 receptor availability in 11 opiate-dependent subjects using PET and [C-11]raclopride at baseline and during naloxone precipitated withdrawal. Because [C-11]raclopride is sensitive to endogenous dopamine, this strategy enabled us to test whether we could document in humans the DA reductions reported in animal models of opiate withdrawal. Results were compared with values from 11 controls, two of which also received naloxone. The ratio of the distribution volume in striatum to that in cerebellum (B-max/K-d+1) was used as model parameter for D-2 receptor availability. Baseline measures for B-max/K-d were lower in opiatedependent subjects (2.44 +/- 0.4) than in controls (2.97 +/- 0.45, p less than or equal to .009). Naloxone precipitated an intense withdrawal in the abusers but did not change the B-max/K-d ratio. This study documents decreases in D-2 receptors in opiate-dependent subjects but does not document significant changes in striatal DA concentration during acute withdrawal. (C) 1997 American College of Neuropsychopharmacology [Neuropsychopharmacology 16:174-182, 1997]
引用
收藏
页码:174 / 182
页数:9
相关论文
共 32 条
[1]   PROFOUND DEPRESSION OF MESOLIMBIC DOPAMINE RELEASE AFTER MORPHINE-WITHDRAWAL IN DEPENDENT RATS [J].
ACQUAS, E ;
CARBONI, E ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 193 (01) :133-134
[2]  
ARY M, 1977, J PHARMACOL EXP THER, V200, P271
[3]  
Blum K, 1996, AM SCI, V84, P132
[4]   COCAINE EFFECTS IN THE VENTRAL TEGMENTAL AREA - EVIDENCE FOR AN INDIRECT DOPAMINERGIC MECHANISM OF ACTION [J].
BRODIE, MS ;
DUNWIDDIE, TV .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1990, 342 (06) :660-665
[5]   STRIATAL BINDING OF THE PET LIGAND C-11 RACLOPRIDE IS ALTERED BY DRUGS THAT MODIFY SYNAPTIC DOPAMINE LEVELS [J].
DEWEY, SL ;
SMITH, GS ;
LOGAN, J ;
BRODIE, JD ;
FOWLER, JS ;
WOLF, AP .
SYNAPSE, 1993, 13 (04) :350-356
[6]   SUBSTITUTED BENZAMIDES AS LIGANDS FOR VISUALIZATION OF DOPAMINE RECEPTOR-BINDING IN THE HUMAN-BRAIN BY POSITRON EMISSION TOMOGRAPHY [J].
FARDE, L ;
EHRIN, E ;
ERIKSSON, L ;
GREITZ, T ;
HALL, H ;
HEDSTROM, CG ;
LITTON, JE ;
SEDVALL, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3863-3867
[7]   INFLUENCE OF LISURIDE ON MORPHINE WITHDRAWAL SIGNS IN THE RAT - A DOPAMINE-MIMETIC EFFECT [J].
FERRARI, F ;
BAGGIO, G .
PSYCHOPHARMACOLOGY, 1982, 78 (04) :326-330
[8]   MODIFICATION OF MORPHINE-INDUCED ANALGESIA, TOLERANCE AND DEPENDENCE BY BROMOCRIPTINE [J].
GOMAA, AA ;
MOHAMED, LH ;
AHMED, HN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 170 (03) :129-135
[9]  
GUNNE LM, 1965, ARCH INT PHARMACOD T, V157, P293
[10]   INVOLVEMENT OF D2 DOPAMINE-RECEPTORS IN THE NUCLEUS-ACCUMBENS IN THE OPIATE WITHDRAWAL SYNDROME [J].
HARRIS, GC ;
ASTONJONES, G .
NATURE, 1994, 371 (6493) :155-157